Jose Antonio Pons

Hepatólogo. Profesor de Medicina. Hospital V. de la Arrixaca.Murcia. Presidente de la Sociedad Española de Trasplante Hepático ( SETH):2017-2021

[Jose Antonio Pons @JoseJoseapons]

Many thanks to J Hepatol for considering our work

[Journal of Hepatology @JHepatology]

Why we wrote this paper:
1⃣Severe #Covid19 reflects a hyperimmune response
2⃣It is unknown how chronic immunosuppression influences the incidence/outcomes of Covid19
3⃣If immunosuppressives⬇️covid19 severity, they could even be treatments
#livertwitter https://t.co/PCh659HaE2

[Jose Antonio Pons @JoseJoseapons]

@HorizonteCuatro Porqué nadie se pregunta qué ocurrió con el cambio radical de Sánchez con respecto al Sáhara. Qué le debe a Marruecos?

[Jose Antonio Pons @JoseJoseapons]

@cayetanaAT @FT Además, habria que preguntarles a dichos diputados, si se sienten bien cuando miran a sus hijos o a sus amigos, rompiendo con la constitución de todos. Pienso que hay que centrar el discurso tb en los diputados del PSOE

[Jose Antonio Pons @JoseJoseapons]

@cayetanaAT @FT Estimada Cayetana. Siendo fundamental centrar la respuesta a Pedro Sanchez, creo que deberían poner de manifiesto la falta de ética y la falta de verguenza de cada uno de los diputados del PSOE.

[Cayetana Álvarez de Toledo @cayetanaAT]

Esto era la convivencia:
un sucio proceso de chantaje.

———
Aragonès exige a Sánchez un referéndum a cambio de garantizar la estabilidad del Gobierno.

Artículo en el @FT
https://t.co/Gkvg082DcO

[Ezequiel Mauro @ezemauro_ok]

Covid-19 vaccination & LT: as in COV-BOOST trial, the key is in the combination. Our ARG Multicentric Study. #transplanttwitter #LiverTwitter @MMendizabalMD @msalnacion @modernavaccine @HepCommJournal @inbirsar @sputnikvaccine https://t.co/gOjGxpNslS

[SandyFeng @SandyFeng8]

Congratulations to the @UABSurgery team!🎇 🥳🎉@amjtransplant is 🦚🙏🥲. Excited for the @nytimes, @WSJ, #mediacoverage to reach our patients! THANK YOU to J. Parsons and family for the gift. SOOOO much to unpack for the future of #transplantation. 🚀 STAY TUNED.

[Jose Antonio Pons @JoseJoseapons]

Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study) https://t.co/nDb8VDkl68

[Imperial Hepatology @IHepatology]

Important new study in @TransplantJrnl exploring de novo malignancy after #livertransplant - new from @DJPinato @ImperialSandC and international @_ILTS_ @SETHepatico colleagues: https://t.co/6gjDkJ6poH

[SETH @SETHepatico]

https://t.co/PFrJoTrrAp

[Jose Antonio Pons @JoseJoseapons]

Do not miss it. Excellent consensus. Consensus Statement on Hemostatic Management,... : Transplantation https://t.co/v3Fldai9UX

[Arturo Pérez-Reverte @perezreverte]

Pues eso.

[Keith Siau @drkeithsiau]

How to prevent food bolus obstruction
https://t.co/vJQwhl6vfa

[Nature Reviews Gastroenterology & Hepatology @NatRevGastroHep]

Online this week: "Machine perfusion of the liver: applications in transplantation and beyond" - Perspective article, read here: https://t.co/BptRLM8Djh
Fig.: Liver preservation:

[Jose Antonio Pons @JoseJoseapons]

@TransplantJrnl @_ILTS_ @SETHepatico excellent consensus of ILTS and SETH. Congratulations!!!

[Transplantation @TransplantJrnl]

The LT with a history of non-hepatic cancer, not sure how to proceed? Read the ILTS-SETH Consensus Conference in the new @TransplantJrnl issue! @_ILTS_ @SETHepatico #VisualAbstract #TransplantTwitter https://t.co/06XzxD4LLl

[Federación Española del Hígado - FEH @fehigado]

⏩ Compartimos con vosotros el posicionamiento de la @SETHepatico respecto al anuncio de tercera dosis para pacientes trasplantados.

Para descargar el documento, pincha aquí 👇
https://t.co/oqEBqwZGkr

[Raquel Blasco @RaquelBlascoR]

REGALAZO!
The @NEJM ha liberado todos los artículos relacionados con #Coronavirus. Aquí os dejo el link:
https://t.co/kSuKFbCNOF. Por favor difundir a todos los conocidos de la comunidad médica y científica.
💯💯💯💯💯RTs!

[Jose Antonio Pons @JoseJoseapons]

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants - The Lancet https://t.co/neWO2ITtsn

[Jose Antonio Pons @JoseJoseapons]

The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments | Nature Reviews Gastroenterology & Hepatology https://t.co/q46knzl9Kh

[Jose Antonio Pons @JoseJoseapons]

Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018 | Cardiology | JAMA | JAMA Network https://t.co/mRcmektJM7